Two alternative product suites have been examined as part of the Scoping Study. This provides the Company with the alternative of producing either a suite of rare earth carbonate products or a suite of separated rare earth oxides. Producing rare earth carbonate products would reduce the initial capital expenditure as the final processing stage would be completed by another party. However, the Scoping Study work indicates that it is preferable to produce a suite of oxide products in order to maximise value for shareholders.
Tonio
CUX Price at posting:
3.2¢ Sentiment: None Disclosure: Not Held